APA (7th ed.) Citation

S, B., L, R., T, M., CA, B., C, T., B, L., . . . JP, R. (2024). Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity. Frontiers in immunology, 15, 1377126. https://doi.org/10.3389/fimmu.2024.1377126

Chicago Style (17th ed.) Citation

S, Bu, et al. "Proteomics Validate Circulating GDF-15 as an Independent Biomarker for COVID-19 Severity." Frontiers in Immunology 15 (2024): 1377126. https://doi.org/10.3389/fimmu.2024.1377126.

MLA (9th ed.) Citation

S, Bu, et al. "Proteomics Validate Circulating GDF-15 as an Independent Biomarker for COVID-19 Severity." Frontiers in Immunology, vol. 15, 2024, p. 1377126, https://doi.org/10.3389/fimmu.2024.1377126.